Video

Optimizing the Use of BCR-ABL TKIs in CML

Transcript:

Related Videos
Minoo Battiwalla, MD, MS
Justin Kaner, MD
Minoo Battiwalla, MD, MS, director, Blood Cancer Outcomes Research, Sarah Cannon Research Institute, TriStar Medical Group
Areej El-Jawahri, MD, associate director, Cancer Outcomes Research and Education Program, director, Bone Marrow Transplant Survivorship Program, associate professor, medicine, Massachusetts General Hospital
Shyam A. Patel, MD, PhD
Amitkumar Mehta, MD
Grzegorz S. Nowakowski, MD
John Seymour, MBBS, FRACP, PhD
Reid Merryman, MD
Partow Kebriaei, MD
Related Content
Jorge Cortes, MD, of Georgia Cancer Center
October 21st 2024

New Global Hematology Journal Strives to Feature Innovative and Adaptable Research

OncLive On Air
March 18th 2024

Revisit the OncLive On Air Episodes From February 2024

Shyam A. Patel, MD, PhD, University of Massachusetts Chan Medical School
October 16th 2024

Donor Clonal Hematopoiesis May Predict Post-Transplant Relapse and Outcomes in Hematologic Malignancies

Matthew Lunning, DO, FACP
November 30th 2023

Lunning and Jacobson Dissect the Role of CAR T-Cell Therapy in Follicular Lymphoma

Ahmed Hamdy, MD, chief executive officer, Vincerx
October 11th 2024

VIP943 Generates Early Complete Responses, Is Safe in Advanced CD123+ Hematologic Malignancies

Armin Ghobadi, MD, of the Washington University School of Medicine
October 7th 2024

NT-I7 After CAR T-Cell Therapy Enhances CAR T Factors in R/R DLBCL